期刊文献+

结核分枝杆菌重组Ag85A、Ag85B蛋白免疫原性的研究 被引量:3

The studies on immunogenicity of Mycobacterium tuberculosis recombinant Ag85A and Ag85B protein
下载PDF
导出
摘要 目的研究结核分枝杆菌重组Ag85A(rAg85A)和/或Ag85B(rAg85B)蛋白与母牛分枝杆菌菌苗(Mycobacteri-um vaccae,MV)联合免疫的免疫原性。方法 60只雌性BALB/c小鼠随机分为下列6组:(1)阴性对照组:磷酸盐缓冲液(PBS)组,(2)阳性对照组:卡介苗(BCG)组,(3)阳性对照组:MV组,(4)实验组:rAg85A-MV组,(5)实验组:rAg85B-MV组及(6)实验组:rAg85A-rAg85B-MV组。每2周免疫1次,共免疫3次。末次免疫结束后第14天杀鼠,用ELISA法检测血清中IgGI、gG1和IgG2a水平;ELISPOT检测脾脏分泌γ干扰素(IFN-γ)的T淋巴细胞斑点数;流式细胞术检测全血单个核细胞内Th1和Th2百分比。结果三个实验组小鼠血清抗体水平均明显高于三个对照组(P<0.001);三个实验组和两个阳性对照组小鼠的T淋巴细胞斑点数均明显高于阴性对照组(P<0.05);rAg85A-rAg85B-MV组小鼠Th1百分比明显高于其余五组(P<0.001),三个实验组Th1/Th2比值均明显高于三个对照组(P<0.05)。结论结核分枝杆菌rAg85A和rAg85B蛋白均具有很强的免疫原性,与MV联合免疫可增强其Th1型细胞免疫应答。 Objective To study the immunogenicity of Mycobacterium tuberculosis rAg85A and/or rAg85B protein joint MV.Methods 60 female BALB/c mice were randomly divided into the following 6 groups:(1)Negative control group:Phosphat buffer solution(PBS),(2) Positive control group:Bacille Calmette-Guerin(BCG),(3) Positive control group:MV,(4) Experimental group:rAg85A-MV,(5) Experimental group:rAg85B-MV,and(6) Experimental group: rAg85A-rAg85B-MV.3 times at 6 weeks intervals.After 6 weeks,all the mice were killed.rAg85A/rAg85B-specific antibodies of IgG,IgG1,and IgG2a were determined by ELISA,the number of T-lymphocytes spots which secreted IFN-γwere detected by ELISPOT,and the percentage of Th1 and Th2 in whole blood mononuclear cells were detected by Flow cytometry.Results The level of three specific antibodies of the three experimental groups were significantly higher than those of the three control groups(P0.001);the number of T-lymphocytes spots of the three experimental groups and two positive control groups were higher than the negative control group(P0.05);the percentage of Th1 of rAg85A-rAg85B-MV group was significantly higher than that of the other 5 groups(P0.001),and the ratio of Th1/Th2 of three experimental groups were higher than the other three control groups(P0.05).Conclusion Mycobacterium tuberculosis rAg85A and rAg85B protein have strong immunogenicity,joint with MV,they can strengthen its Th1-type immune response.
出处 《中国实验诊断学》 北大核心 2011年第10期1618-1621,共4页 Chinese Journal of Laboratory Diagnosis
基金 国家重大传染病专项资助(基金编号2008ZX-10003-013) 解放军第309医院基金资助(基金编号2007AY04) WHO基金资助(基金编号V25-181-202) 解放军总医院创新基金资助(基金编号06ZY31) 吉林省科技厅课题(200505115201115079)
关键词 结核分枝杆菌 AG85A AG85B 母牛分枝杆菌 疫苗 Mycobacterium tuberculosis Ag85A Ag85B Mycobacterium vaccae vaccine
  • 相关文献

参考文献13

  • 1Zwerling A,Behr MA,et al.The BCG World Atlas:A Database of Global BCG Vaccination Policies and Practices[J].PLos Medicine,2011,8(3):1001.
  • 2Stanford JL,Bahr GM,et al.Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis[J].Tubercle,1990,71(2):87.
  • 3陈兰举,潘家华,陈名武,张慧洁,丁周志,沈怀云,周瑞.结核感染小鼠肺部病理变化与T细胞免疫关系的实验研究[J].中国微生态学杂志,2008,20(3):213-215. 被引量:1
  • 4Nagdev KJ,Kashyap RS,et al.Comparative evaluation of a PCR assay with an in-house ELISA method for diagnosis of Tuberculous meningitis[J].Med Sci Monit,2010,16(6):289.
  • 5Skinner MA,Yuan S,et al.Immunization with heat-killed Mycobacterium vaccae stimulates CD+8 cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis[J].Infection and Immunity,1997,65 (11):4525.
  • 6Johnson JL,Kamya RM,et al.Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis[J].J Infect Dis,2000,181(4):1304.
  • 7曹赋,李文志.母牛分枝杆菌菌苗治疗难治性肺结核病疗效观察[J].中国社区医师(医学专业),2010,12(23):26-26. 被引量:4
  • 8周晔,蒋天舒,陈燕,娄加陶,吴传勇,陈波,谷明莉,仲人前,邓安梅.结核杆菌Ag85A重组蛋白的免疫原性研究[J].中国实验诊断学,2007,11(9):1153-1155. 被引量:2
  • 9Giri PK,Verma I,et al.Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection[J].Immunotherapy,2009,1(1):31.
  • 10Giri PK,Verma I,et al.Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration[J].FEMS Immunol Med Microbiol,2006,47(2):233.

二级参考文献24

共引文献4

同被引文献63

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部